FDA Adverse Event Injury Summary report: N

HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM

MDR report key: 10541125 · Received September 16, 2020

Report

Report Number
2916596-2020-04372
Event Type
Injury
Date Received
September 16, 2020
Date of Event
March 1, 2020
Report Date
September 16, 2020
Manufacturer
THORATEC CORPORATION
Product Code
DSQ
PMA / PMN Number
P160054
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE HEARTMATE 3 LVAS WAS IMPLANTED DURING THE MOMENTUM 3 CLINICAL TRIAL, IDE# G140113. FDA APPROVAL FOR HEARTMATE 3 LVAS WAS RECEIVED ON 23 AUGUST 2017. THE GTIN UNIQUE DEVICE IDENTIFIER FOR THE COMMERCIAL HEARTMATE3 LVAS IS (B)(4). THE PUMP REMAINS IN USE SUPPORTING THE PATIENT. A CORRELATION BETWEEN THE DEVICE AND THE REPORT OF INFECTION COULD NOT BE CONCLUSIVELY DETERMINED. INFECTION IS LISTED IN THE INSTRUCTIONS FOR USE AS A POTENTIAL ADVERSE EVENT THAT MAY BE ASSOCIATED WITH THE USE OF {HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM}. INFECTION HAS BEEN PREVIOUSLY INVESTIGATED AND WILL CONTINUE TO BE MONITORED THROUGH QUALITY DATA REVIEWS, WHICH ARE CONDUCTED ON PRODUCTION AND POST PRODUCT SIGNALS TO EVALUATE IF PRODUCTS ARE CONFORMING TO PRODUCT REQUIREMENTS. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WITH A PSEUDOMONAS DRIVELINE INFECTION BECAME INCREASINGLY RESISTANT TO ANTIBIOTICS AND STRUGGLED TO NEPHROTOXIC SIDE EFFECTS. EVENT OCCURED IN (B)(6) 2020

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1006557 HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM VENTRICULAR (ASSISST) BYPASS DSQ THORATEC CORPORATION 106524 5851353

Patients

Seq Age Sex Outcome Treatment
1 57 YR Hospitalization| R